Propulia Capital
206-2170 Boul. René-Levesque W, Montréal, QC, H3H 2T9, Canada
Overview
Propulia Capital is a venture capital firm that prefers to invest in seed, early and later-stage companies.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Banking
- Business Development
- Venture Capital
Investment portfolio
- Solfium
Participated · Seed · Nov 2023
Solfium offers a unified clean-energy platform that integrates solar generation with energy management systems, battery storage, electric vehicle chargers, and predictive maintenance while connecting suppliers, distributors, employees, and corporate facilities. The company reports that since 2022 it has installed 36,260 solar panels, adding 25 MW of capacity and projected to reduce 281,000 tons of CO2 over 25 years while delivering roughly USD 28 million in savings to customers and electricity consumers. Solfium’s leadership emphasizes enabling access to clean energy for both large corporates and more than five million MSMEs in Mexico, with ambitions to expand further across Latin America. The company closed a $10 million Series A to strengthen its technology stack and accelerate market expansion, with strategic investor support from BDC Capital and LATAM Impact Fund aimed at validating impact and scaling operations. CEO and cofounder Andrés Friedman has highlighted customer energy-cost reductions of up to 95% as a key value proposition. Solfium is headquartered in Montreal and is using its platform and new capital to deepen presence in Mexico and grow distributed solar deployment.
- Kiro
Participated · Series A · Mar 2023
Kiro provides an AI-powered digital health platform for clinical biology that interprets laboratory data and generates medically validated reports within seconds. Developed in partnership with laboratories, hospitals and physicians, its solutions offer personalized results for patients and caregivers and deliver real-time clinical decision support tools for prevention and diagnosis. The platform leverages laboratory results to improve patient outcomes and to help healthcare providers follow and treat patients more efficiently. Founded in 2019 and led by CEO Alexandre Guenoun, Kiro is based in Paris, France. The company plans to use the Series A proceeds to further develop its technology and platform, reinforce its position in France, expand commercial operations across Europe, and prepare entry into the US market. The round brought the company's total funding to €17M.
Team
No current team members are available.